Lokon Pharma Initiates a Collaboration with Affibody to Develop Novel Cancer Therapeutics
Lokon Pharma AB, a leading biotech company in the area of immunostimulatory gene therapy for cancer delivered by uniquely engineered oncolytic viruses, today announced a collaboration with Affibody AB to develop a novel therapeutic strategy to treat cancer.
“Lokon’s oncolytic adenovirus platform encodes human immunostimulatory genes to induce anti-tumor immunity in cancer patients. We already h